Cargando…

The Latest Drugs in Development That Reduce Intraocular Pressure in Ocular Hypertension and Glaucoma

Glaucoma causes irreversible vision loss, with elevated intraocular pressure (IOP) being the only known modifiable risk factor. There are a variety of medical and interventional options for lowering IOP; however, despite these treatments, glaucoma continues to be a leading cause of visual impairment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jayanetti, Viran, Sandhu, Sartaj, Lusthaus, Jed A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685378/ https://www.ncbi.nlm.nih.gov/pubmed/33244278 http://dx.doi.org/10.2147/JEP.S281187

Ejemplares similares

Recently Approved Drugs for Lowering and Controlling Intraocular Pressure to Reduce Vision Loss in Ocular Hypertensive and Glaucoma Patients
por: Sharif, Najam A.
Publicado: (2023)

Safety and tolerability of tafluprost in treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
por: Pozarowska, Dorota
Publicado: (2010)

Clinical appraisal of tafluprost in the reduction of elevated intraocular pressure (IOP) in open-angle glaucoma and ocular hypertension
por: Aihara, Makoto
Publicado: (2010)

Multicenter Effectiveness and Disease Stability Through 3 Years After iStentTrabecular Micro-Bypass with Phacoemulsification in Glaucoma and Ocular Hypertension
por: Clement, Colin, et al.
Publicado: (2022)

First-line treatment for elevated intraocular pressure (IOP) associated with open-angle glaucoma or ocular hypertension: focus on bimatoprost
por: Law, Simon K
Publicado: (2007)

Two-Year Multicenter Outcomes of iStent inject Trabecular Micro-Bypass Stents Combined with Phacoemulsification in Various Types of Glaucoma and Ocular Hypertension
por: Clement, Colin, et al.
Publicado: (2020)

Spectral analysis of intraocular pressure pulse wave in ocular hypertensive and primary open angle glaucoma patients
por: Bozic, Marija M, et al.
Publicado: (2016)

Intraocular pressure 1 year after vitrectomy in eyes without a history of glaucoma or ocular hypertension
por: Fang, Yuan, et al.
Publicado: (2017)

Corneal biomechanics and biomechanically corrected intraocular pressure in primary open-angle glaucoma, ocular hypertension and controls
por: Vinciguerra, Riccardo, et al.
Publicado: (2020)

Effect of Tratak (Yogic Ocular Exercises) on Intraocular Pressure in Glaucoma: An RCT
por: Sankalp,, et al.
Publicado: (2022)

Two-year outcomes of patients presenting to Sydney Eye Hospital with neovascular glaucoma
por: Kingston, Ezekiel J., et al.
Publicado: (2023)

Role of fixed-combination brinzolamide 1%/timolol 0.5% in the treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
por: Beckers, Henny JM, et al.
Publicado: (2009)

Ahmed Glaucoma Valve Implantation to Reduce Intraocular Pressure: Updated Perspectives
por: Arikan, Gul, et al.
Publicado: (2023)

Twenty-Four-Hour Intraocular Pressure Control with Omidenepag Isopropyl 0.002% in Patients with Glaucoma and Ocular Hypertension
por: Shiratori, Naka, et al.
Publicado: (2021)

Ocular Accommodation, Intraocular Pressure, Development of Myopia and Glaucoma: Role of Ciliary Muscle, Choroid and Metabolism
por: Aggarwala, Karan R Gregg
Publicado: (2020)

Tafluprost for the Reduction of Interocular Pressure in Open Angle Glaucoma and Ocular Hypertension
por: Schultz, Clyde
Publicado: (2011)

Role of Histamine H(3) Receptor Antagonists on Intraocular Pressure Reduction in Rabbit Models of Transient Ocular Hypertension and Glaucoma
por: Lanzi, Cecilia, et al.
Publicado: (2019)

Erroneous assumption of ocular hypertension in patients with elevated intraocular pressure
por: Rewri, Parveen, et al.
Publicado: (2022)

Efficacy and tolerability of mono-compound topical treatments for reduction of intraocular pressure in patients with primary open angle glaucoma or ocular hypertension: an overview of reviews
por: Daka, Qëndresë, et al.
Publicado: (2014)

Fixed combination of travoprost and timolol maleate reduces intraocular pressure in Japanese patients with primary open-angle glaucoma or ocular hypertension: analysis by prostaglandin analogue
por: Nakano, Tadashi, et al.
Publicado: (2016)

Brimonidine in the treatment of glaucoma and ocular hypertension
por: Cantor, Louis B
Publicado: (2006)

Relationship of systemic blood pressure with ocular perfusion pressure and intraocular pressure of glaucoma patients in telemedical home monitoring
por: Jürgens, Clemens, et al.
Publicado: (2012)

Short-term reproducibility of intraocular pressure and ocular perfusion pressure measurements in Chinese volunteers and glaucoma patients
por: Gao, Yanlin, et al.
Publicado: (2016)

The effect of changes in intraocular pressure on the risk of primary open-angle glaucoma in patients with ocular hypertension: an application of latent class analysis
por: Gao, Feng, et al.
Publicado: (2012)

Long-Term Intraocular Pressure-Lowering Effects and Adverse Events of Ripasudil in Patients with Glaucoma or Ocular Hypertension over 24 Months
por: Tanihara, Hidenobu, et al.
Publicado: (2022)

Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension
por: Lee, Anne J, et al.
Publicado: (2010)

Current situation and progress of drugs for reducing intraocular pressure
por: Liu, Peiyu, et al.
Publicado: (2022)

Cataract surgery reduces intraocular pressure but not posture-induced intraocular pressure changes in patients with angle-closure glaucoma
por: Chang, Pei-Yao, et al.
Publicado: (2019)

The impact of topical intraocular pressure lowering medications on the ocular surface of glaucoma patients: A review
por: Asiedu, Kofi, et al.
Publicado: (2018)

Effect of Yoga-Based Ocular Exercises in Lowering of Intraocular Pressure in Glaucoma Patients: An Affirmative Proposition
por: Sankalp,, et al.
Publicado: (2018)

Statin Use in Relation to Intraocular Pressure, Glaucoma, and Ocular Coherence Tomography Parameters in the UK Biobank
por: Kim, Jihye, et al.
Publicado: (2022)

Latest Developments in Normal-Pressure Glaucoma: Diagnosis, Epidemiology, Genetics, Etiology, Causes and Mechanisms to Management
por: Lee, Jacky W.Y., et al.
Publicado: (2019)

Intraocular pressure-lowering efficacy and safety of bimatoprost 0.03% therapy for primary open-angle glaucoma and ocular hypertension patients in China
por: Wang, Kaidi, et al.
Publicado: (2014)

Short-Term Reproducibility of Twenty-Four-Hour Intraocular Pressure Curves in Untreated Patients with Primary Open-Angle Glaucoma and Ocular Hypertension
por: Xu, Shuo, et al.
Publicado: (2015)

Correlation between ocular perfusion pressure and ocular pulse amplitude in glaucoma, ocular hypertension, and normal eyes
por: Figueiredo, Bruno P, et al.
Publicado: (2013)

The management of glaucoma and intraocular hypertension: current approaches and recent advances
por: Noecker, Robert J
Publicado: (2006)

Change of Retinal Vessel Density After Lowering Intraocular Pressure in Ocular Hypertension
por: Chen, Xuhao, et al.
Publicado: (2021)

Dynamic Contour Tonometry in Primary Open Angle Glaucoma and Pseudoexfoliation Glaucoma: Factors Associated with Intraocular Pressure and Ocular Pulse Amplitude
por: Moghimi, Sasan, et al.
Publicado: (2013)

Intraocular pressure and glaucoma: Is physical exercise beneficial or a risk?
por: McMonnies, Charles William
Publicado: (2016)

The Latest Evidence of Erythropoietin in the Treatment of Glaucoma
por: Lin, Ting-Yi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sqk7mtbb56ood54lpe832ir851